期刊文献+

控释纳米粒的研究进展 被引量:3

下载PDF
导出
作者 桂卉 范学工
出处 《中成药》 CAS CSCD 北大核心 2004年第11期938-940,共3页 Chinese Traditional Patent Medicine
基金 国家"8 63"项目 (2 0 0 1AA2 180 11) 湖南省教育厅科研基金资助项目 (湘教通 [2 0 0 1] 2 0 7)
  • 相关文献

参考文献19

  • 1Koert N. J. Burger, Rutger W. H. M. Staffhorst, et al. Nanocapsules:lipid-coated aggregates of cisplatin with high cytotoxicity[J]. Naturemedicine 2002,8(1) :81-84.
  • 2Guo JX, Ping QN, Zhang L, et al. Transdermal delivery of insulinin mice by using lecithin vesicles as a career[J]. Drug DelivSyst, 2000,7:113-116.
  • 3Guo JX, Ping QN, Chen Y. Lecithin vesicular carriers for transdermal delivery of cyclosporin A [J]. IntJPharm, 2000,194: 201-207.
  • 4Soppimath KS, Aminabhavi TM, Kulkarni AR, et al. Biodegrad ablepokymeric nanoparticles as a drug delivery devices[J].J Controlled Reslease, 2001,70:1-20.
  • 5Jung T, Kamm W, Breitenbach A, et al. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosalup take [J]. EurJ Pharm Biopharm,2000,50 : 147-160.
  • 6Mehnet W, Mader K. Solid lipid nanoparticles: prodution, characterization and applications [J ]. Adv Drug Deliv Rev,2001,47(2/3): 165-196.
  • 7Muller RH, Mader K, Gohla S. Solid lipid nanoparticles(SLN) for controlled drug delivery a review of thestate of theart [J].Eur J Pharm Biopharm, 2000,50:161-177.
  • 8Sakuma S, Hayashi M, Akashi M, et al. Design of nanoparticles composed of graft copolymers for oral peptide delivery [J]. Adv Deliv Rev, 2001,47(1) :21-37.
  • 9Jenning V, Gohla SH. Encapsulation of retinoids in solid lipid nanoparticles(SLN)[J]. JMicroen capsulations, 2001, 18:149- 158.
  • 10Kim SY, Lee YM. Taxol-loaded block copolymer nanospheres composed of methoxy poly (ethylene glycol) and poly ( epsfloncaprolactone) as novel anticancer drug carriers[ J ]. Biomaterials,2001,22(13):1679-1704.

同被引文献35

  • 1刘明星,董静,杨亚江,杨祥良,徐辉碧.雷公藤甲素聚乳酸纳米粒的制备及毒性[J].药学学报,2004,39(7):556-560. 被引量:29
  • 2曾莉,凌立君,周玉春,夏国守,陈海燕,林娜.活血通腑方对大鼠术后腹腔粘连的实验研究[J].中国中西医结合外科杂志,2005,11(2):135-137. 被引量:11
  • 3王汝兴,刘翠哲,刘喜纲.纳米技术及其在药学研究中的应用[J].承德医学院学报,2005,22(3):248-249. 被引量:1
  • 4蒋立新,赵郁,凌立君.活血化瘀中药对小鼠术后腹腔粘连组织中胶原含量影响的研究[J].中国血液流变学杂志,2006,16(1):46-48. 被引量:10
  • 5Abeezar I, SarelaN S, Jane R et al. Immuno histo chemical detection of the anti-apoptosis protein, survivin, predicts sur- vival after curative resection of stage II colorectal carcinomas [J]. Ann Surg Oncol, 2001, 8(4) : 305-310.
  • 6Kwak C, Ku J H, Park J Y, et al. Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer[J]. J Urol, 2004, 171 (1): 149-152.
  • 7Scott-Coombers D,Whawell S A,Vipond M N,et al.Hunanintraperitoneal fibrinolytic response to surgery[J].Bri J Surg,1995,82:414.
  • 8Sarela AI,Scott N,Ramsdale J,et al.Immuno histo chemicaldetection of the anti-apoptosis protein,survivin,predicts surviv-al after curative resection of stage II colorectal Carcinomas[J].Ann Surg Oncol,2001,8(4):305-310.
  • 9Kwk C,Ku J H,Park J Y,et al.Initial tumor stage and gradeas a predictive factor for recurrence in patients with stage T1Grade 3 bladder cancer[J].J Urolo,2004,171(1):149-152.
  • 10Peng Q,Zhang Z R,Sun X,et al.Mechanisms of phospho-lipid complex loaded nanoparticles enhancing the oral bioavail-ability[J].Mol Pharm,2010,7(2):565-575.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部